Erythroid Neoplasm

hematologic malignancy

Identifier: CI-CAN-00000851
Entity page: /cancer/erythroid-neoplasm ↗
Edges: 330

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Erythroid Neoplasm approved for …APPROVED_FORderived3 of 3
← approved for	Ruxolitinibsmall molecule FDA (US) · approved · 2026-05-01 · polycythemia vera in adults who have had an inadequate response to or are intolerant of hydroxyurea.	—	approved	Polycythemia Vera	1	Regulatory	openfda	graph →
← approved for	Ropeginterferon Alfa-2bother

Erythroid Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 67show all (up to 200)
→ investigated in trials for	Cytarabinesmall molecule 31 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	31	Observed	clinicaltrials	graph →
→ investigated in trials for	Ruxolitinibsmall molecule 23 trials (8 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	23	Observed	clinicaltrials	graph →
→ investigated in trials for	Fludarabinesmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	19	Observed	clinicaltrials	graph →
→ investigated in trials for	Etoposidesmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	13	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamidesmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	12	Observed	clinicaltrials	graph →
→ investigated in trials for	Mitoxantronesmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	11	Observed	clinicaltrials	graph →
→ investigated in trials for	Busulfansmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Tipifarnibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	10	Observed	clinicaltrials	graph →
→ investigated in trials for	Azacitidinesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Idarubicinsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Ropeginterferon Alfa-2bother 9 trials (5 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	9	Observed	clinicaltrials	graph →
→ investigated in trials for	Daunorubicinsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	7	Observed	clinicaltrials	graph →
→ investigated in trials for	Alvocidibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Aspirinsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	6	Observed	clinicaltrials	graph →
→ investigated in trials for	Bortezomibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants	—	—	Erythroid Neoplasm	6	Observed	clinicaltrials	graph →

Erythroid Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 67show all (up to 200)

→ investigated in trials for

Cytarabinesmall molecule

31 trials (0 active) · roll-up of the cancer and its descendants

—

Erythroid Neoplasm

Observed

Erythroid Neoplasm studied in …STUDIED_INderived10 of 260show all (up to 200)
→ studied in	NCT07722611Phase 2/Phase 3 · recruiting A Clinical Trial of Bomedemstat in Participants With Polycythemia Vera (MK-3543-025) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT05548062active not recruiting Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT07839858completed A Study of Real-world Use and Effectiveness of Cytoreductive Strategies for the Treatment of Second-line Polycythemia Vera in France · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT07469891Phase 1 · recruiting A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT04282187Phase 2 · recruiting Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT01831635completed Myeloproliferative Neoplasms: an In-depth Case-control Study · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT07429266Phase 3 · recruiting INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT07648030Phase 2 · recruiting A Study of Rusfertide in Japanese Adults With Polycythemia Vera · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT06661915Phase 2 · recruiting A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs) · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →
→ studied in	NCT07765602Phase 2 · not yet recruiting A Study of Rusfertide in Adults With Polycythemia Vera in China · condition mapped ONTOLOGY_EXACT · 260 trials mapped (59 active)	—	—	Polycythemia Vera	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains